Role of the electrocardiogram in determining electrophysiologic end points of drug therapy
- 19 October 1988
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 62 (12) , H34-H38
- https://doi.org/10.1016/0002-9149(88)90338-4
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Antiarrhythmic activity, electrocardiographic effects and pharmacokinetics of the encainide metabolites O-desmethyl encainide and 3-methoxy-O-desmethyl encainide in man.Circulation, 1988
- Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainideJournal of the American College of Cardiology, 1986
- Spectrum of antiarrhythmic response to encainideThe American Journal of Cardiology, 1985
- Rate-dependent effects of intravenous lidocaine, procainamide and amiodarone on intraventricular conductionJournal of the American College of Cardiology, 1985
- Effects of flecainide on the electrophysiologic properties of isolated canine and rabbit myocardial fibersJournal of the American College of Cardiology, 1985
- Antiarrhythmic Agents: The Modulated Receptor Mechanism of Action of Sodium and Calcium Channel-Blocking DrugsAnnual Review of Pharmacology and Toxicology, 1984
- Amiodarone dosing: A proposal based on its pharmacokineticsAmerican Heart Journal, 1983
- Importance of metabolites in antiarrhythmic therapyThe American Journal of Cardiology, 1983
- Kinetics of antifibrillatory effects of bretylium: Correlation with myocardial drug concentrationsThe American Journal of Cardiology, 1980
- Electrophysiologic comparative study of procainamide and N-acetylprocainamide in anesthetized dogs: concentration-response relationships.Circulation, 1979